Tirzepatide activates both GIP and GLP-1 receptors, while semaglutide activates GLP-1 receptors
Additionally, about one-fifth of adults who use GLP-1 agonists reported having experienced vomiting
Microbial components and effector molecules in T helper cell differentiation and function
K., Reimann, F., & Liberles, S
Inside experimental environments, the SermorelinIpamorelin blend has been theorized to impact regulatory pathways that coordinate cellular renewal mechanisms
In summary, you can generally continue your other medications while on NAD+ injections, but keep your medical team informed and always follow their advice if they prefer to adjust dosing schedules or monitor certain lab parameters